We have previously reported that STING restrains MDSC differentiation by decreasing IL1β and IL-6 production from NPC or CD33+ cells through suppressing the SOCS1/STAT3 signaling pathway22. This evidence concerns the gene STING1 and nasopharyngeal carcinoma.